However, these associations appear to be stronger and more consistent in luminal A and B tumours and weaker in Her2-enriched and basal-like tumours, although it is important to note that differences in sample sizes for each subtype may have contributed to this result. The gene discussed is ERBB2; the disease is neoplasm.